Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Deloitte
QuintilesIMS
Colorcon
McKesson
AstraZeneca
US Department of Justice
Daiichi Sankyo
Covington

Generated: February 21, 2018

DrugPatentWatch Database Preview

CEVIMELINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Cevimeline Hydrochloride patents expire, and when can generic versions of Cevimeline Hydrochloride launch?

Cevimeline Hydrochloride is a drug marketed by Apotex Inc, Novel Labs Inc, Rising Pharms Inc, and West-ward Pharms Int. and is included in four NDAs.

The generic ingredient in CEVIMELINE HYDROCHLORIDE is cevimeline hydrochloride. There are four drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.
Drug patent expirations by year for CEVIMELINE HYDROCHLORIDE
Pharmacology for CEVIMELINE HYDROCHLORIDE

US Patents and Regulatory Information for CEVIMELINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc CEVIMELINE HYDROCHLORIDE cevimeline hydrochloride CAPSULE;ORAL 091260-001 Aug 25, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CEVIMELINE HYDROCHLORIDE cevimeline hydrochloride CAPSULE;ORAL 091591-001 Jul 8, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novel Labs Inc CEVIMELINE HYDROCHLORIDE cevimeline hydrochloride CAPSULE;ORAL 204746-001 Dec 30, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rising Pharms Inc CEVIMELINE HYDROCHLORIDE cevimeline hydrochloride CAPSULE;ORAL 203775-001 Jun 4, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Deloitte
Healthtrust
Harvard Business School
Chinese Patent Office
Mallinckrodt
Accenture
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot